Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
CStone announces first patient dosed in the Phase III trial of CS1001 in combination with chemotherapy in first-line esophageal squamous cell carcinoma 2020-01-08 13:45
Daewoong Pharmaceutical Receives World's First Halal Certification for Biopharmaceutical Product Derived from Animal Cells through Indonesian Joint Venture, Daewoong Infion 2020-01-08 11:00
Hummingbird Bioscience Publishes Preclinical Data Demonstrating Efficacy of HMBD-001 in HER3 Driven Cancers 2020-01-08 10:40
Rapid Diagnostics Announces Completion of Asset Purchase and New Corporate Strategies 2020-01-08 08:00
Innovent and Sirnaomics Entered Strategic Collaboration to Conduct Clinical Oncology Studies Combining Sintilimab and RNAi in the US 2020-01-08 08:00
Rising Demand for IoT-enabled Pumps to Drive North American PD Pumps Market amid Economic Slowdown 2020-01-08 06:03
Southstar Drug Gets Ready for the Future with Huawei Wi-Fi 6 2020-01-08 00:01
LumaCyte Awarded Frost & Sullivan 2019 Global Single-Cell Analysis New Product Innovation Award for Its Novel Laser Force Cytology™ Technology 2020-01-07 20:07
Continued Success of Novoheart to Receive R&D Grants: Innovation Technology Fund for Developing Smart Cardiac Screening Technologies 2020-01-07 17:39
Mundipharma Announces Exclusive Deal for Biosolution's CartiLife(R) in South Korea 2020-01-07 11:37
genOway and Merck Strengthen CRISPR/Cas9 Strategic Alliance by Extending Their Partnership to All Animal Cell Models 2020-01-07 09:00
InxMed Announces Clinical Collaboration with MSD to Evaluate IN10018 in Combination with Pembrolizumab 2020-01-07 08:25
Japanese Clinical Study of DiscGenics' Cell Therapy for Disc Degeneration Passes Initial Safety Review 2020-01-07 08:00
Inovio Provides Update on Clinical Program Plans for 2020 2020-01-06 21:00
12th Consecutive Year Leading United States in Organ Donation for Gift of Life Donor Program 2020-01-06 20:00
BAVENCIO Significantly Improved Overall Survival in Patients With Locally Advanced or Metastatic Urothelial Carcinoma 2020-01-06 20:00
Antengene Corporation Appoints Former Celgene China GM John Chin as Chief Business Officer 2020-01-06 20:00
Dr. Nalini Rajamannan Comments on FDA Congressional Letter to Senate Finance Committee After Kaiser Health News Reveals Access to Exempt FDA Database 2020-01-06 19:00
Abcam Announces Successful Acquisition of Expedeon's Proteomics and Immunology Business, Enhancing Its Conjugation Capability 2020-01-06 15:00
Yisheng Biopharma and Tavotek Biotherapeutics Announce Strategic Research Alliance for Development of YS-ON-001/002 and Tavo-301/303 Combination Therapy for Cancer Treatment 2020-01-06 09:00
1 396 397 398 399 400 538